Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Gustavo Verdier, BSc, BPharm, MBA
ViiV Healthcare, Montréal, QC, Canada, Canada
Disclosure(s): ViiV Healthcare: Employee
Poster(s):
(P-357) The Global REGAL cohort: A REtrospective real-world study of the effectiveness and tolerability of the antiretroviral treatment reGimens DTG/3TC compAred to BIC/FTC/TAF in older persons Living with HIV
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET
(P-360) Real-world Effectiveness and Safety Outcomes in People with HIV-1 Switching to Dolutegravir + Lamivudine (DTG + 3TC) with Unknown Prior Genotype: a Systematic Literature Review and Meta-analysis
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET
(P-376) The US REGAL Cohort: A Retrospective Real-world Study of the Effectiveness and Tolerability of the Antiretroviral Treatment Regimens DTG/3TC Compared to BIC/FTC/TAF in Older Persons Living with HIV
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET
